NCT01302899View on ClinicalTrials.gov

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Non-diabetic Nephropathy
Interventions
DRUG

Aliskiren

Aliskiren 150 mg (Tablet)

DRUG

Placebo to Aliskiren

Aliskiren 150 mg Matching Placebo (Tablet)

DRUG

Hydrochlorothiazide (HCTZ)

HCTZ 25mg (Capsule)

DRUG

Placebo to Hydrochlorothiazide (HCTZ)

HCTZ 25mg (Capsule) Matching Placebo

DRUG

Ramipril

Ramipril 10mg (Tablet)

Trial Locations (2)

Unknown

Novartis Investigative Site, Groningen

Novartis Investigative Site, Leeuwarden

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY